Published in Brain on September 01, 1974
CFS hydroxylase cofactor levels in some neurological diseases. J Neurol Neurosurg Psychiatry (1980) 1.59
Of mice, rats and men: Revisiting the quinolinic acid hypothesis of Huntington's disease. Prog Neurobiol (2009) 1.18
Studies of hypothalamic function in Huntington's chorea. J Neurol Neurosurg Psychiatry (1981) 1.16
Mouse models of Huntington's disease and methodological considerations for therapeutic trials. Biochim Biophys Acta (2009) 1.14
The topographic distribution of brain atrophy in Huntington's disease and progressive supranuclear palsy. Acta Neuropathol (1993) 1.13
Regional distribution of choline acetyltransferase in the human brain: changes in Huntington's chorea. J Neurol Neurosurg Psychiatry (1975) 1.05
Some ethical problems in Huntington's chorea. Can Med Assoc J (1981) 1.02
Homovanilic acid in Huntington's disease and Sydenham's chorea. J Neurol Neurosurg Psychiatry (1981) 0.98
Biochemical aspects of Huntington's chorea. J Neurol Neurosurg Psychiatry (1977) 0.97
Striatal cholinergic interneuron regulation and circuit effects. Front Synaptic Neurosci (2014) 0.91
Functional anatomy of movement disorders. J Anat (2000) 0.90
The role of dopamine in Huntington's disease. Prog Brain Res (2014) 0.89
3-Hydroxyanthranilate oxygenase activity is increased in the brains of Huntington disease victims. Proc Natl Acad Sci U S A (1988) 0.88
Neuroendocrine markers of CNS drug effects. Br J Clin Pharmacol (1980) 0.87
Growth hormone and prolactin response to bromocriptine in patients with Huntington's chorea. J Neurol Neurosurg Psychiatry (1978) 0.86
Huntington's-chorea fibroblasts. Cellular protein glycosylation. Biochem J (1980) 0.85
Platelet monoamine oxidase activity in Huntington's chorea. J Neurol Neurosurg Psychiatry (1978) 0.82
Regulation of quinolinic acid neosynthesis in mouse, rat and human brain by iron and iron chelators in vitro. J Neural Transm (Vienna) (2011) 0.80
Chemical pathology of brain degeneration. Proc R Soc Med (1977) 0.79
Subcortical afferent projection systems in Huntington's chorea. Acta Neuropathol (1989) 0.78
Quantification of reserve pool dopamine in methionine sulfoxide reductase A null mice. Neuroscience (2011) 0.77
Spin label electron paramagnetic resonance (EPR) studies of Huntington disease erythrocyte membranes. Am J Hum Genet (1982) 0.77
Effects of GABA, glycine, and sodium barbiturate on dendritic growth in vitro. Acta Neuropathol (1983) 0.76
CSF choline levels in groups of patients with cranial trauma or extrapyramidal disorders. J Neurol Neurosurg Psychiatry (1984) 0.75
Regional brain atrophy and reductions in glutamate release and uptake after intrastriatal kainic acid. Br J Pharmacol (1978) 0.75
Neither Physicians Nor Surgeons: Whither Neuropathological Skill in Post-war England? Med Hist (2015) 0.75
Lack of effect of 4-aminopyridine on choreic movements. J Neurol Neurosurg Psychiatry (1982) 0.75
2-dimethylaminoethanol (Deanol) in Huntington's chorea. J Neurol Neurosurg Psychiatry (1978) 0.75
Neurochemistry and behavior in man. West J Med (1976) 0.75
Neuropathological classification of Huntington's disease. J Neuropathol Exp Neurol (1985) 7.93
Regional studies of catecholamines in the rat brain. I. The disposition of [3H]norepinephrine, [3H]dopamine and [3H]dopa in various regions of the brain. J Neurochem (1966) 7.91
The uptake of [3H]GABA by slices of rat cerebral cortex. J Neurochem (1968) 5.05
The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist. Proc Natl Acad Sci U S A (1986) 3.97
Role of transmitter uptake mechanisms in synaptic neurotransmission. Br J Pharmacol (1971) 3.82
Predictive testing for Huntington's disease with use of a linked DNA marker. N Engl J Med (1988) 3.82
Effects of 6-hydroxydopamine on catecholamine containing neurones in the rat brain. J Neurochem (1970) 3.42
The role of uptake2 in the extraneuronal metabolism of catecholamines in the isolated rat heart. Br J Pharmacol (1969) 3.25
Inhibition of catecholamine Uptake-2 by steroids in the isolated rat heart. Br J Pharmacol (1970) 3.07
Opiate analgesics inhibit substance P release from rat trigeminal nucleus. Nature (1977) 2.74
Cerebral amyloid angiopathy without and with cerebral hemorrhages: a comparative histological study. Ann Neurol (1991) 2.70
Oxidative damage and metabolic dysfunction in Huntington's disease: selective vulnerability of the basal ganglia. Ann Neurol (1997) 2.64
The retrograde axonal transport of nerve growth factor. Brain Res (1974) 2.60
Deficits in small interneurons in prefrontal and cingulate cortices of schizophrenic and schizoaffective patients. Arch Gen Psychiatry (1991) 2.55
Release of gamma-aminobutyric acid from inhibitory nerves of lobster. Proc Natl Acad Sci U S A (1966) 2.47
Multiple opiate receptor sites on primary afferent fibres. Nature (1980) 2.34
Factors associated with slow progression in Huntington's disease. Arch Neurol (1991) 2.18
The possible existence of multiple receptors for substance P. Naunyn Schmiedebergs Arch Pharmacol (1982) 2.18
Selective sparing of a class of striatal neurons in Huntington's disease. Science (1985) 2.16
The physiologic disposition and metabolism of norepinephrine in immunosympathectomized animals. J Pharmacol Exp Ther (1966) 2.03
GABA uptake in rat central nervous system: comparison of uptake in slices and homogenates and the effects of some inhibitors. J Neurochem (1971) 2.00
Trans-synaptic regulation of growth and development of adrenergic neurones in a mouse sympathetic ganglion. Brain Res (1971) 1.99
7-Chlorokynurenic acid is a selective antagonist at the glycine modulatory site of the N-methyl-D-aspartate receptor complex. Proc Natl Acad Sci U S A (1988) 1.99
Release of dopamine from dendrites in rat substantia nigra. Nature (1976) 1.95
Reduced uptake of tritiated noradrenaline in tissues of immunosympathectomized animals. Nature (1965) 1.91
Autoradiographic localization of 3 H-GABA in rat retina. Nat New Biol (1972) 1.90
Effects of phenoxybenzamine on the uptake and metabolism of noradrenaline in the rat heart and vas deferens. Br J Pharmacol (1969) 1.90
Multiple tachykinin binding sites in peripheral tissues and in brain. Eur J Pharmacol (1986) 1.86
An improved approach to prepare human brains for research. J Neuropathol Exp Neurol (1995) 1.84
Catecholamine uptake processes. Br Med Bull (1973) 1.83
Quantitative cytoarchitectural studies of the cerebral cortex of schizophrenics. Arch Gen Psychiatry (1986) 1.83
Uptake and metabolism of gamma-aminobutyric acid by neurones and glial cells. Biochem Pharmacol (1975) 1.83
The inhibition of noradrenaline uptake by drugs. Adv Drug Res (1965) 1.82
Use of catechol O-methyltransferase for the enzyme radiochemical assay of dopamine. J Neurochem (1973) 1.82
Capsaicin-induced depletion of substance P from primary sensory neurones. Brain Res (1978) 1.80
Kynurenic acid concentrations are reduced in Huntington's disease cerebral cortex. J Neurol Sci (1992) 1.79
Inhibition of PC12 cell redox activity is a specific, early indicator of the mechanism of beta-amyloid-mediated cell death. Proc Natl Acad Sci U S A (1994) 1.79
Dopamine receptors in the brain. Science (1975) 1.79
Neurochemical characteristics of early and late onset types of Alzheimer's disease. Br Med J (Clin Res Ed) (1984) 1.78
Uptake mechanisms for neurotransmitter amines. Biochem Pharmacol (1974) 1.73
Increased GABAA receptor binding in superficial layers of cingulate cortex in schizophrenics. J Neurosci (1992) 1.68
Tissue selectivity of substance P alkyl esters: suggesting multiple receptors. Eur J Pharmacol (1983) 1.65
Maternal transmission in Huntington's disease. Lancet (1983) 1.64
Sodium dependence of transmitter uptake at adrenergic nerve terminals. Mol Pharmacol (1966) 1.63
Clinical and neuropathologic assessment of severity in Huntington's disease. Neurology (1988) 1.62
A post-mortem study of the cholinergic and GABA systems in senile dementia. Brain (1982) 1.62
Evidence for the GluR6 gene associated with younger onset age of Huntington's disease. Neurology (1999) 1.60
The release of gamma-aminobutyric acid during inhibition in the cat visual cortex. J Physiol (1971) 1.59
Uptake, storage and metabolism of norepinephrine in tissues of the developing rat. J Pharmacol Exp Ther (1967) 1.58
Human brain dopamine receptors in children and aging adults. Synapse (1987) 1.55
Differences in the regulation of tyrosine hydroxylase and dopa decarboxylase in sympathetic ganglia and adrenals. Nat New Biol (1971) 1.54
Another mechanism for creating diversity in gamma-aminobutyrate type A receptors: RNA splicing directs expression of two forms of gamma 2 phosphorylation site. Proc Natl Acad Sci U S A (1990) 1.53
A sex related factor in the inheritance of Huntington's chorea. Ann Hum Genet (1974) 1.51
Biochemical and anatomical observations on the degeneration of peptide-containing primary afferent neurons after neonatal capsaicin. Neuroscience (1981) 1.50
Quantitative neuropathological changes in presymptomatic Huntington's disease. Ann Neurol (2001) 1.44
A quantitative ultrastructural and biochemical analysis of the process of reinnervation of the superior cervical ganglion in the adult rat. Brain Res (1974) 1.43
An analysis of the arrangement of neurons in the cingulate cortex of schizophrenic patients. Arch Gen Psychiatry (1987) 1.38
Naloxone as a GABA antagonist: evidence from iontophoretic, receptor binding and convulsant studies. Eur J Pharmacol (1978) 1.38
Smoking...harmful to the brain. Nature (1996) 1.37
Enhancement of H-3-norepinephrine uptake in rat tissues by O-methylated metabolites of catecholamines. J Pharmacol Exp Ther (1966) 1.36
The amyloid beta protein gene is not duplicated in brains from patients with Alzheimer's disease. Science (1987) 1.35
Subcellular distribution of endogenous and (3H) gamma-aminobutyric acid in rat cerebral cortex. J Neurochem (1969) 1.35
A corticosteroid/dopamine hypothesis for psychotic depression and related states. J Psychiatr Res (1985) 1.33
Morphometric analysis of the prefrontal cortex in Huntington's disease. Neurology (1991) 1.30
The uptake and storage of H3-norepinephrine in the reserpine-pretreated rat heart. J Pharmacol Exp Ther (1965) 1.30
Effects of surgical decentralization and nerve growth factor on the maturation of adrenergic neurons in a mouse sympathetic ganglion. J Neurochem (1972) 1.28
Decreased neuronal and increased oligodendroglial densities in Huntington's disease caudate nucleus. J Neuropathol Exp Neurol (1991) 1.27
Regional mitochondrial respiratory activity in Huntington's disease brain. J Neurochem (1985) 1.25
Glycine uptake in rat central nervous system slices and homogenates: evidence for different uptake systems in spinal cord and cerebral cortex. J Neurochem (1971) 1.24
Release and metabolism of substance P in rat hypothalamus. Nature (1976) 1.24
Regional studies of catecholamines in the rat brain. II. Rate of turnover of catecholamines in various brain regions. J Neurochem (1966) 1.23
Purification and characterisation of a membrane-bound substance-P-degrading enzyme from human brain. Eur J Biochem (1981) 1.22
Reduced amounts of immunoreactive somatostatin in the temporal cortex in senile dementia of Alzheimer type. Neurosci Lett (1980) 1.21
Late-onset Hallervorden-Spatz disease presenting as familial parkinsonism. Neurology (1985) 1.21
Calcium-dependent release of somatostatin and neurotensin from rat brain in vitro. Nature (1978) 1.21
Effects of 6-hydroxydopamine on noradrenaline-containing neurones in the rat brain. Nature (1969) 1.20
Human brain D1 and D2 dopamine receptors in schizophrenia, Alzheimer's, Parkinson's, and Huntington's diseases. Neuropsychopharmacology (1987) 1.20
Molecular cloning of a serotonin receptor from human brain (5HT1E): a fifth 5HT1-like subtype. Proc Natl Acad Sci U S A (1992) 1.19
The metabolism of gamma-aminobutyric acid (GABA) in the lobster nervous system--uptake of GABA in the nerve-muscle preparations. J Neurochem (1968) 1.19
Basic fibroblast growth factor in Alzheimer's disease. Biochem Biophys Res Commun (1990) 1.19
Levels of the growth-associated protein GAP-43 are selectively increased in association cortices in schizophrenia. Proc Natl Acad Sci U S A (1996) 1.19
Kynurenine pathway measurements in Huntington's disease striatum: evidence for reduced formation of kynurenic acid. J Neurochem (1990) 1.19
Dose-dependent effects of capsaicin on primary sensory neurons in the neonatal rat. J Neurosci (1983) 1.18
Regional studies of catecholamines in the rat brain. IV. Effects of drugs on the disposition and metabolism of H3-norepinephrine and H3-dopamine. J Pharmacol Exp Ther (1966) 1.18
Studies of the uptake of 3 H-gaba and ( 3 H)glycine in slices and homogenates of rat brain and spinal cord by electron microscopic autoradiography. Brain Res (1972) 1.18
Lysosomal proteinase antigens are prominently localized within senile plaques of Alzheimer's disease: evidence for a neuronal origin. Brain Res (1990) 1.18
Mechanism of inositol monophosphatase, the putative target of lithium therapy. Proc Natl Acad Sci U S A (1994) 1.18
Late onset of Huntington's disease. J Neurol Neurosurg Psychiatry (1985) 1.18
Localizing 3H-GABA in nerve terminals of rat cerebral cortex by electron microscopic autoradiography. Nature (1971) 1.18
Reduced neuronal size in posterior hippocampus of schizophrenic patients. Schizophr Bull (1991) 1.15
Decreased pyruvate dehydrogenase complex activity in Huntington and Alzheimer brain. Ann Neurol (1983) 1.15
Kynurenine pathway abnormalities in Parkinson's disease. Neurology (1992) 1.14
Noradrenaline metabolizing enzymes in normal and sympathetically denervated vas deferens. J Neurochem (1971) 1.12
Morphologic and histochemical characteristics of a spared subset of striatal neurons in Huntington's disease. J Neuropathol Exp Neurol (1987) 1.12
Effect of iodinated water supplies on thyroid function. J Clin Endocrinol Metab (1966) 1.12
The glycine site on the NMDA receptor: structure-activity relationships and therapeutic potential. J Med Chem (1994) 1.12
Loss of pigmented dopamine-beta-hydroxylase positive cells from locus coeruleus in senile dementia of Alzheimer's type. Neurosci Lett (1983) 1.12
Quinolinic acid phosphoribosyltransferase in human and rat brain: activity in Huntington's disease and in quinolinate-lesioned rat striatum. Brain Res (1985) 1.10
A quantitative comparison of the formation of synapses in the rat superior cervical sympathetic ganglion by its own and by foreign nerve fibres. Brain Res (1976) 1.10
The role of post-synaptic neurones in the biochemical maturation of presynaptic cholinergic nerve terminals in a mouse sympathetic ganglion. J Physiol (1972) 1.10